Orion (Finland) Overview

  • Year Founded
  • 1917

Year Founded

  • Status
  • Public

  • Employees
  • 4,174

Employees

  • Stock Symbol
  • ORNAV

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $111.53
  • (As of Tuesday Closing)

Orion (Finland) General Information

Description

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Orionintie 1A
  • 02200 Espoo
  • Finland
+358 010
Primary Industry
Pharmaceuticals
Other Industries
Other Commercial Products
Other Pharmaceuticals and Biotechnology
Stock Exchange
HEL
Vertical(s)
Corporate Office
  • Orionintie 1A
  • 02200 Espoo
  • Finland
+358 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orion (Finland) Stock Performance

As of 17-Nov-2026, Orion (Finland)’s stock price is $111.53. Its current market cap is $15.7B with 140M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$111.53 $113.33 $67.93 - $115.26 $15.7B 140M 7.08K $5.44

Orion (Finland) Financials Summary

As of 30-Sep-2026, Orion (Finland) has a trailing 12-month revenue of $2.53B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 13,206,708 10,631,458 6,331,673 6,234,467
Revenue 2,529,134 2,131,368 1,669,029 1,287,237
EBITDA 963,529 768,623 500,795 346,805
Net Income 765,316 564,341 356,984 234,594
Total Assets 2,306,480 2,360,749 1,695,196 1,590,228
Total Debt 142,319 358,611 340,579 221,191
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Orion (Finland) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orion (Finland)‘s full profile, request access.

Request a free trial

Orion (Finland) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and vete
Pharmaceuticals
Espoo, Finland
4,174 As of 2026

Unterach, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orion (Finland) Competitors (1)

One of Orion (Finland)’s competitors is Ever Pharma, a Corporation company based in Unterach, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ever Pharma Corporation Unterach, Austria
You’re viewing 1 of 1 competitors. Get the full list »

Orion (Finland) Patents

Orion (Finland) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-242852-S Packaging for foodstuffs Active 05-Aug-2025
US-D1141940-S1 Packaging Active 17-Jun-2025
WO-2026180566-A1 Antigen binding molecules Pending 28-Feb-2025
WO-2026132683-A1 Piperidine derivatives useful as gpr183 antagonists Pending 20-Dec-2024
WO-2026136294-A1 Probiotic compositions of p. hiranonis and methods Pending 16-Dec-2024 A61P1/12
To view Orion (Finland)’s complete patent history, request access »

Orion (Finland) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orion (Finland) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Orion (Finland)‘s full profile, request access.

Request a free trial

Orion (Finland) Investments & Acquisitions (7)

Orion (Finland)’s most recent deal was a Early Stage VC with Eion for . The deal was made on 25-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Eion 25-Sep-2024 Early Stage VC Environmental Services (B2B)
V.M.D. 15-Jun-2022 Merger/Acquisition Other Commercial Products
Knit Finance 07-May-2021 Seed Round Financial Software
AffaMed Therapeutics 30-Mar-2021 PE Growth/Expansion Drug Discovery
PharmaService (Finland) 26-Nov-2010 Secondary Transaction - Private Other Devices and Supplies
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Orion (Finland) ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

20.49 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Orion (Finland)’s complete esg history, request access »

Orion (Finland) Exits (4)

Orion (Finland)’s most recent exit was on 25-Sep-2024 from Eion. The exit was categorized as with 11 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Eion 25-Sep-2024 Completed
  • 11 buyers
PharmaService (Finland) 26-Nov-2010 Completed
Kronans Droghandel 01-Jul-2002 Completed
Kronans Droghandel Corporate Completed
To view Orion (Finland)’s complete exits history, request access »

Orion (Finland) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Orion Pharma (UK) London, United Kingdom 1988
Orion Pension Fund Espoo, Finland

Orion (Finland) FAQs

  • When was Orion (Finland) founded?

    Orion (Finland) was founded in 1917.

  • Where is Orion (Finland) headquartered?

    Orion (Finland) is headquartered in Espoo, Finland.

  • What is the size of Orion (Finland)?

    Orion (Finland) has 4,174 total employees.

  • What industry is Orion (Finland) in?

    Orion (Finland)’s primary industry is Pharmaceuticals.

  • Is Orion (Finland) a private or public company?

    Orion (Finland) is a Public company.

  • What is Orion (Finland)’s stock symbol?

    The ticker symbol for Orion (Finland) is ORNAV.

  • What is the current stock price of Orion (Finland)?

    As of 17-Nov-2026 the stock price of Orion (Finland) is $111.53.

  • What is the current market cap of Orion (Finland)?

    The current market capitalization of Orion (Finland) is $15.7B.

  • What is Orion (Finland)’s current revenue?

    The trailing twelve month revenue for Orion (Finland) is $2.53B.

  • Who are Orion (Finland)’s competitors?

    Ever Pharma is a competitor of Orion (Finland).

  • What is Orion (Finland)’s annual earnings per share (EPS)?

    Orion (Finland)’s EPS for 12 months was $5.44.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process